Clinicopathological characterization of mouse models of melanoma

Abstract

Mouse models of melanoma have proven invaluable in the delineation of key molecular events involved in disease progression in humans and provide potential preclinical models for therapeutic testing (Damsky and Bosenberg, Pigment Cell Melanoma Res 25(4):404–405, 2012; Walker et al., Pigment Cell Melanoma Res 24(6):1158–1176, 2011). Here we concentrate on the clinicopathological analysis of melanocytic tumors.